Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY

Bel Fuse Cl B Receives IBD Stock Rating Upgrade

Bel Fuse Cl B saw an improvement in its IBD SmartSelect Composite Rating Monday, from 93 to 97.

Looking For Winning Stocks? How To Invest In Both Bull And Bear Markets

The revised score means the stock currently tops 97% of all other stocks in terms of key performance metrics and technical strength. History shows the top market performers tend to have a 95 or higher score as they launch their major moves.

Bel Fuse Cl B has now climbed above a proper buy zone after clearing the 92.61 entry in a consolidation.

One weak spot is the company's 75 EPS Rating, which tracks quarterly and annual earnings-per-share growth. Look for that to improve to 80 or better to show it's in the top 20% of all stocks.

Its Accumulation/Distribution Rating of A shows heavy buying by institutional investors over the last 13 weeks.

In Q2, the company reported -2% EPS growth. Top line growth climbed 26%, up from 19% in the prior report. The company has now posted rising growth in each of the last three quarters.

Bel Fuse Cl B holds the No. 3 rank among its peers in the Electronics-Parts industry group. Amphenol Cl A is the top-ranked stock within the group.

This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.